Similar Papers

Paper Title
Journal
Date
Author
Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis
Robert J Kurman ... Ie-Ming Shih
American Journal of Obstetrics and Gynecology | VOL. 198
Robert J Kurman, et. al.Robert J Kurman ... Ie-Ming Shih
01 Apr 2008
Abstract 4002: Identification of signal transduction pathway activity with potential clinical target in high-grade serous ovarian carcinoma
Phyllis Van Der Ploeg ... Jurgen M.J Piek
Cancer Research | VOL. 82
Phyllis Van Der Ploeg, et. al.Phyllis Van Der Ploeg ... Jurgen M.J Piek
15 Jun 2022
Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma
...
Zhonghua fu chan ke za zhi | VOL. 52
, et. al. ...
25 Oct 2017
MicroRNA Profiling of BRCA1/2 Mutation-Carrying and Non-Mutation-Carrying High-Grade Serous Carcinomas of Ovary
Cheng-Han Lee ... Shirley X Zhu
PLoS ONE | VOL. 4
Cheng-Han Lee, et. al.Cheng-Han Lee ... Shirley X Zhu
02 Oct 2009
View more papers

More From: Gynecologic Oncology

Paper Title
Journal
Date
Author
Chemotherapy Response Score (CRS): A comprehensive review of its prognostic and predictive value in High-Grade Serous Carcinoma (HGSC).
Gian Franco Zannoni ... Angela Santoro
Gynecologic oncology | VOL. 194
Gian Franco Zannoni, et. al.Gian Franco Zannoni ... Angela Santoro
06 Feb 2025
High prevalence of FAP+ cancer-associated fibroblasts predicts poor outcome in patients with high-grade serous ovarian cancer with high CD8 T-cell density.
Sara Corvigno ... Hanna Dahlstrand
Gynecologic oncology | VOL. 193
Sara Corvigno, et. al.Sara Corvigno ... Hanna Dahlstrand
01 Feb 2025
Serum CA125 levels in the context of ProMisE molecular classification provides pre-operative prognostic information that can direct endometrial cancer management.
Andrea Neilson ... Jessica N Mcalpine
Gynecologic oncology | VOL. 193
Andrea Neilson, et. al.Andrea Neilson ... Jessica N Mcalpine
01 Feb 2025
What happens after menopause? (WHAM): A prospective controlled study of cognition 24months after premenopausal risk-reducing salpingo-oophorectomy.
Pauline M Maki ... Martha Hickey
Gynecologic oncology | VOL. 193
Pauline M Maki, et. al.Pauline M Maki ... Martha Hickey
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.